enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
-
Salah tirade adds to Slot's troubles during Liverpool slump
-
Torres treble helps Barca extend Liga lead, Atletico slip
-
PSG thump Rennes but Lens remain top in France
-
Salah opens door to Liverpool exit with 'thrown under the bus' rant
-
Two eagles lift Straka to World Challenge lead over Scheffler
-
Messi dazzles as Miami beat Vancouver to win MLS title
-
Bielle-Biarrey strikes twice as Bordeaux-Begles win Champions Cup opener in S.Africa
-
Bilbao's Berenguer deals Atletico another Liga defeat
-
Salah opens door to Liverpool exit after being 'thrown under the bus'
-
Bethlehem Christmas tree lit up for first time since Gaza war
-
Slot shows no sign of finding answers to Liverpool slump
-
New Zealand's Robinson wins giant slalom at Mont Tremblant
-
Liverpool slump self-inflicted, says Slot
-
Hundreds in Tunisia protest against government
-
Mofokeng's first goal wins cup final for Orlando Pirates
-
Torres hat-trick helps Barca down Betis to extend Liga lead
-
Bielle-Biarrey strikes twice as Bordeaux win Champions Cup opener in S.Africa
-
Liverpool humbled again by Leeds fightback for 3-3 draw
-
'Democracy has crumbled!': Four arrested in UK Crown Jewels protest
-
Contenders plot path to 2026 World Cup glory as FIFA reveals tournament schedule
-
Inter thump Como to top Serie A ahead of Liverpool visit
-
Maresca fears Chelsea striker Delap faces fresh injury setback
-
Consistency the key to Man City title charge – Guardiola
-
Thauvin on target again as Lens remain top in France
-
Greyness and solitude: French ex-president describes prison stay
-
Frank relieved after Spurs ease pressure on under-fire boss
-
England kick off World Cup bid in Dallas as 2026 schedule confirmed
-
Milei welcomes Argentina's first F-16 fighter jets
-
No breakthrough at 'constructive' Ukraine-US talks
-
Bielle-Biarrey double helps Bordeaux-Begles open Champions Cup defence with Bulls win
-
Verstappen looking for a slice of luck to claim fifth title
-
Kane cameo hat-trick as Bayern blast past Stuttgart
-
King Kohli says 'free in mind' after stellar ODI show
-
Arsenal rocked by Aston Villa, Man City cut gap to two points
-
Crestfallen Hamilton hits new low with Q1 exit
-
Sleepless in Abu Dhabi - nervy times for Norris says Rosberg
-
Arsenal will bounce back from Villa blow: Arteta
-
UN Security Council delegation urges all sides to stick to Lebanon truce
-
Verstappen outguns McLarens to take key pole in Abu Dhabi
-
Syria's Kurds hail 'positive impact' of Turkey peace talks
-
Verstappen takes pole position for season-ending Abu Dhabi GP
-
Jaiswal hits ton as India thrash S. Africa to clinch ODI series
-
UK's Farage rallies in Scottish town hit by immigration protests
-
Saracens kick off European campaign by crushing Clermont
-
Arsenal rocked by Villa as Buendia ends leaders' unbeaten run
-
Venezuela's Machado vows to make Nobel Peace Prize ceremony
-
Kidnapping fears strain family bonds in Nigeria
-
'Chosen' Mbappe on way to making Real Madrid history like Ronaldo: Alonso
-
Russian strikes on Ukraine trigger heating, water cuts
-
Mediators Qatar, Egypt call for next steps in Gaza truce
NYSE - LSE
| RBGPF | 0% | 78.35 | $ | |
| CMSD | -0.3% | 23.25 | $ | |
| JRI | 0.29% | 13.79 | $ | |
| SCS | -0.56% | 16.14 | $ | |
| BCC | -1.66% | 73.05 | $ | |
| NGG | -0.66% | 75.41 | $ | |
| RYCEF | -0.34% | 14.62 | $ | |
| CMSC | -0.21% | 23.43 | $ | |
| RELX | -0.55% | 40.32 | $ | |
| BCE | 1.4% | 23.55 | $ | |
| RIO | -0.92% | 73.06 | $ | |
| GSK | -0.33% | 48.41 | $ | |
| VOD | -1.31% | 12.47 | $ | |
| BTI | -1.81% | 57.01 | $ | |
| AZN | 0.17% | 90.18 | $ | |
| BP | -3.91% | 35.83 | $ |
enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
Watch the "What This Means" video here
IRVINE, CA / ACCESS Newswire / September 26, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that Robert Berman, Chief Executive Officer of enVVeno Medical participated in a Virtual Investor "What This Means" segment.
As part of the segment, Mr. Berman discussed the Company's recent news announcing it filed a request for supervisory appeal of the not-approvable letter from the Center for Devices and Radiological Health (CDRH) of the U.S. Food & Drug Administration (FDA) received on August 19, 2025, in response to its Premarket Approval (PMA) application for the VenoValve®, a surgical replacement venous valve for treating severe deep chronic venous insufficiency (CVI).
The Virtual Investor "What This Means" segment featuring enVVeno Medical is now available here.
About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of severe deep Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The Company is currently performing the final testing necessary to seek IDE approval from the FDA to begin the U.S. pivotal trial for enVVe.
INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
[email protected]
(908) 824-0775
MEDIA CONTACT:
Glenn Silver, FINN Partners
[email protected]
(973) 818-8198
SOURCE: enVVeno Medical Corporation
View the original press release on ACCESS Newswire
T.Perez--AT
